RESEARCH FRONT
56
C. M. Kormos, R. M. Hull, and N. E. Leadbeater
General Experimental Procedure for the Preparation
of 1,4-Dihydropyridines: Preparation of 1
the remaining pressure was carefully vented. The solvent was
removed under vacuum. 1H and 13C NMR in CDCl3 indicated
>95% conversion to 8a. Liquid chromatography mass spectro-
metry was used to verify the product and determine the propor-
tion of de-alkylation, if any. δH (CDCl3, 500 MHz) 0.91 (6H, t,
J 7.1), 2.62 (6H, s), 4.01 (4H, q, J 7.2), 7.24–7.38 (5H, m). δC
(CDCl3, 126 MHz) 14.3, 19.6, 39.6, 59.7, 104.2, 126.1, 127.8,
128.0, 143.9, 147.8, 167.7.
Benzaldehyde (0.51 mL, 5 mmol), ethyl acetoacetate (2.15 mL,
17 mmol), concentrated aqueous ammonium hydroxide (2.8 mL,
4.1 mmol), water (5 mL), and ethanol (5 mL) were combined in a
100-mL round-bottom long-neck flask equipped with a stir bar.
The flask was placed into the microwave cavity and a reflux con-
denser attached to the flask. The solution was heated to reflux
(84◦C) and then held at this temperature for a further 25 min.
The contents of the vessel were allowed to cool to 60◦C, and then
poured onto ice (30 g). The crude product was filtered, washed
with water, dissolved in ethyl acetate (50 mL), and washed with
water. The organic phase was dried over magnesium sulfate, fil-
tered, and concentrated under reduced pressure to afford diethyl
2,6-dimethyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate 1
(1.18 g, 72% yield) as a light yellow solid. δH (CDCl3, 500 MHz)
1.23–1.26 (6H, m), 2.34 (6H, s), 4.08–4.15 (4H, m), 5.01 (1H, s),
5.75 (bs), 7.14 (1H, t, J 6.7), 7.23 (2H, t, J 7.5), 7.30 (2H, d, J
8.0). δC (CDCl3, 126 MHz) 14.3, 19.6, 39.6, 59.7, 104.2, 126.1,
127.8, 128.0, 143.9, 147.8, 167.7.
NMR Data for Other Pyridines Prepared
in the Present Study
9a: δH (CDCl3, 500 MHz) 0.93–1.30 (6H, m), 1.32 (6H, t, J 7.1),
1.56–1.80 (5H, m), 2.32 (6H, s), 3.95 (1H, d, J 5.7), 4.13–4.27
(4H, m), 5.61 (1H, bs). δC (CDCl3, 126 MHz) 14.4, 19.5, 26.6,
26.7, 28.8, 38.4, 45.8, 59.6, 102.0, 144.4, 168.7.
10a: δH (CDCl3, 400 MHz) 2.06 (3H, s), 2.43 (6H, s), 2.48
(6H, s). δC (CDCl3, 100 MHz) 16.1, 21.8, 32.2, 135.9, 151.7,
175.6, 205.5.
11a: δH (CDCl3, 300 MHz) 0.86 (3H, m), 1.40 (3H, t, J 7.1),
1.10–1.40 (6H, m), 2.83 (6H, s), 3.98 (2H, t, J 6.6), 4.38 (4H, q,
J 7.1). δC (CDCl3, 75 MHz) 13.9, 14.2, 22.2, 22.4, 24.5, 27.3,
28.0, 61.5, 123.2, 141.1, 162.1, 165.8.
11b: δH (CDCl3, 500 MHz) 1.41 (6H, t, J 7.1), 2.85 (6H, s),
4.40 (4H, q, J 7.2), 8.69 (1H, s). δC (CDCl3, 126 MHz) 14.3,
24.4, 61.5, 123.4, 141.2, 162.1, 165.8.
13a: δH (CDCl3, 300 MHz) 1.57 (18H, s), 2.78 (6H, s), 8.52
(1H, s). δC (CDCl3, 75 MHz) 24.5, 28.2, 82.3, 124.9, 141.0,
161.0, 165.2.
NMR Data for Other 1,4-Dihydropyridines Prepared
in the Present Study
2: δH (CDCl3, 500 MHz) 0.93–1.30 (6H, m), 1.32 (6H, t, J 7.1),
1.56–1.80 (5H, m), 2.32 (6H, s), 3.95 (1H, d, J 5.7), 4.13–4.27
(4H, m), 5.61 (1H, bs). δC (CDCl3, 126 MHz) 14.4, 19.5, 26.6,
26.7, 28.8, 38.4, 45.8, 59.6, 102.0, 144.4, 168.7.
3: δH (CDCl3, 300 MHz) 0.86 (3H, t, J 7.0), 1.15–1.35
(14H, m), 2.30 (6H, s), 3.94 (1H, t, J 5.8), 4.04–4.29 (4H, m),
5.53 (1H, bs).
4: δH ([D6]DMSO, 400 MHz) 2.09 (6H, s), 5.10 (1H, s), 6.96
(2H, t, J 7.3), 7.08 (1H, t, J 6.8), 7.18–7.24 (8H, m), 7.54 (4H,
d, J 7.9), 8.05 (s, 1H), 9.28 (2H, s). δC ([D6]DMSO, 100 MHz)
17.3, 42.0, 105.7, 119.4, 122.6, 125.9, 127.1, 128.0, 128.4, 137.8,
139.5, 167.4.
Acknowledgements
The American Chemical Society Petroleum Research Fund is thanked for
funding (45433-AC1). Milestone srl is thanked for equipment support and
provision of electrodeless discharge lamps. Assistance with liquid chro-
matography mass spectrometry analysis fromTzipporah Kertesz is gratefully
acknowledged.
5: δH (CDCl3, 400 MHz) 1.10 (6H, s), 1.24 (6H, s), 2.29–2.49
(8H, m), 5.54 (1H, s), 7.09 (2H, d, J 7.8), 7.17 (1H, t, J 7.1),
7.26 (2H, m), 11.90 (1H, bs). δC (CDCl3, 100 MHz) 27.4, 29.7,
31.4, 32.8, 46.5, 47.1, 115.6, 125.8, 126.8, 128.2, 138.1, 190.4.
6: δH (CDCl3, 300 MHz) 0.76 (2H, q, J 10.9), 1.07 (6H, s),
1.09 (6H, s), 1.16–1.35 (3H, m), 1.58–1.75 (5H, m), 2.20–2.40
(8H, m), 2.49–2.68 (1H, m), 3.60 (1H, d, J 11.1), 11.5 (1H, bs).
7: δH (CDCl3, 300 MHz) 0.85 (6H, d, J 6.8), 1.07 (6H, s),
1.10 (6H, s), 2.24–2.38 (8H, m), 2.93–2.98 (1H, m), 3.48 (1H,
d, J 11.1), 11.5 (1H, bs).
References
[1] For
a recent review see: G. M. Reddy, M. Shiradkar,
A. K. Chakravarthy, Curr. Org. Chem. 2007, 11, 847. doi:10.2174/
138527207781024058
[2] A. E. Thompson, J. E. Pope, Rheumatology 2005, 44, 145.
doi:10.1093/RHEUMATOLOGY/KEH390
[3] P. A. Poole-Wilson, B. A. Kirwan, Z. Vokó, S. de Brouwer,
F. J. van Dalen, J. Lubsen, Cardiovasc. Drugs Ther. 2006, 20, 45.
doi:10.1007/S10557-006-6312-4
[4] X.-Q. Zhu,Y.-C. Liu, B.-J. Zhao, J.-P. Cheng, J. Org. Chem. 2001, 66,
370. doi:10.1021/JO0009696
[5] K.-J. Schleifer, J. Med. Chem. 1999, 42, 2204. doi:10.1021/
JM981114C
General Experimental Procedure for the Oxidation
of 1,4-Dihydropyridines: Preparation of 8a
To a quartz reaction vessel was added 1 (104.2 mg, 0.316 mmol),
acetonitrile (7.5 mL), and the EDL. The vessel was sealed
with the screw-top with ports for gas-addition and fibre optic
temperature measurement. A pressure of 1000 kPa oxygen was
introduced, then vented to the atmosphere. This process was
repeated three times. A final charge of 1000 kPa oxygen
was introduced. The vessel was then sealed, the temperature
probe inserted, and the vessel placed in the microwave cavity.
The reaction was heated to 150◦C with a 600W maximum for
the first minute of heating, then the maximum was decreased to
250W. An external pressurized air line was fitted into the ves-
sel jacket so that the vessel could be cooled enough to require
more than 100W to maintain the desired temperature of 150◦C.
After 20 min at 150◦C, the reaction was cooled to 50◦C; then
[6] S. Visentin, P. Amiel, R. Frittero, D. Boschi, C. Roussel,
L. Giusta, E. Carbone, A. Gasco, J. Med. Chem. 1999, 42, 1422.
doi:10.1021/JM980623B
[7] A. Di Stilo, S. Visentin, C. Clara, A. M. Gasco, G. Ermondi,
A. J. Gasco, J. Med. Chem. 1998, 41, 5393. doi:10.1021/JM9803267
[8] R. A. Coburn, M. Wierzba, M. J. Suto, A. J. Solo, A. M. Triggle,
D. J. Triggle, J. Med. Chem. 1988, 31, 2103. doi:10.1021/
JM00119A009
[9] For
a recent review see: A. I. Matern, V. N. Charushin,
O. N. Chupakhin, Russ. Chem. Rev. 2007, 76, 23. doi:10.1070/
RC2007V076N01ABEH003647
[10] A. Hantzsch, Justus Liebigs Ann. Chem. 1882, 215, 1. doi:10.1002/
JLAC.18822150102
[11] For a review see: J. J. Vanden Eynde, A. Mayence, Molecules 2003, 8,
381. doi:10.3390/80400381